Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridine⁻Pyrazole Hybrid Derivatives

Flefel, EM; El-Sofany, WI; El-Shahat, M; Naqvi, A; Assirey, E

HERO ID

4923467

Reference Type

Journal Article

Year

2018

Language

English

PMID

30301217

HERO ID 4923467
In Press No
Year 2018
Title Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridine⁻Pyrazole Hybrid Derivatives
Authors Flefel, EM; El-Sofany, WI; El-Shahat, M; Naqvi, A; Assirey, E
Journal Molecules
Volume 23
Issue 10
Page Numbers 2548-2548
Abstract A series of novel pyridine and fused pyridine derivatives have been prepared starting from 6-(3,4-dimethylphenyl)-2-hydrazinyl-4-(thiophen-2-yl)-pyridine-3-carbonitrile 1 which on treatment with appropriate formic acid, acetic acid/ acetic anhydride, benzoyl chloride and/or carbon disulfide afforded the corresponding triazolopyridine derivatives 2⁻5. Also, treatment of hydrazide 1 with diethyloxalate, chloroacetyl chloride, chloroacetic acid and/or 1,2-dichloroethane yielded the corresponding pyridotriazine derivatives 7⁻10. Further transformation of compound 1 with a different active methylene group, namely acetyl acetone, diethylmalonate, ethyl cyanoacetate, ethyl benzoylacetate and/or ethyl acetoacetate, produced the pyridine⁻pyrazole hybrid derivatives 11⁻15. These newly synthesized compounds (1⁻15) were subjected to in silico molecular docking screenings towards GlcN-6-P synthase as the target protein. The results revealed moderate to good binding energies of the ligands on the target protein. All the newly prepared products exhibited antimicrobial and antioxidant activity.
Doi 10.3390/molecules23102548
Pmid 30301217
Wosid WOS:000451201400144
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English